---
schema_version: "secwatch.filing_event.v1"
accession: "0001528287-25-000030"
form_type: "8-K"
ticker: "NPCE"
cik: "0001528287"
company_name: "NeuroPace Inc"
filed_at: "2025-11-04T23:59:59+00:00"
generated_at: "2026-05-17T00:36:53.441847+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# NeuroPace reports record Q3 revenue $27.4M (+30% YoY); raises FY2025 guidance

## Summary
- Record quarterly revenue of $27.4M, up 30% YoY; RNS System revenue $22.6M (+31% YoY).
- Gross margin expanded to 77.4% from 73.2% YoY; operating loss narrowed to $2.6M from $4.2M.
- Net loss improved to $3.5M from $5.5M YoY; cash and short-term investments $60M.
- Raised FY2025 revenue guidance to $97M-$98M (21-23% YoY growth) and gross margin to 76%-77%.
- On track to submit NAUTILUS PMA supplement to FDA for IGE indication expansion by year-end 2025.

## SEC filing metadata
- accession: 0001528287-25-000030
- form_type: 8-K
- ticker: NPCE
- cik: 0001528287
- company_name: NeuroPace Inc
- filed_at: 2025-11-04T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1528287/000152828725000030/0001528287-25-000030-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1528287/000152828725000030/npce-20251104.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001528287-25-000030
- JSON: https://secwatch.observer/filing/0001528287-25-000030.json
- Plain text: https://secwatch.observer/filing/0001528287-25-000030.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.